Quarterly report pursuant to Section 13 or 15(d)

Note 8 - Financing Arrangements (Details Textual)

v3.24.0.1
Note 8 - Financing Arrangements (Details Textual) - USD ($)
3 Months Ended 9 Months Ended
Dec. 31, 2023
Jan. 01, 2023
Dec. 31, 2023
Jan. 01, 2023
Jul. 02, 2023
Apr. 02, 2023
Selling, General and Administrative Expense $ 4,107,000 $ 2,742,000 $ 12,189,000 $ 8,891,000    
Long-Term Line of Credit 10,000,000   10,000,000     $ 12,700,000
Letters of Credit Outstanding, Amount 0   0     0
Line of Credit Facility, Remaining Borrowing Capacity 19,800,000   19,800,000     20,000,000
Accounts Receivable, after Allowance for Credit Loss, Current 22,000,000   22,000,000     22,800,000
Accounts Receivable, Allowance for Credit Loss, Current 2,500,000   2,500,000     1,500,000
Receivable Due from Factor [Member]            
Accounts Receivable, Allowance for Credit Loss, Current 17,600,000   17,600,000     $ 20,700,000
Revolving Credit Facility [Member]            
Line of Credit Facility, Maximum Borrowing Capacity $ 35,000,000   $ 35,000,000      
Revolving Credit Facility [Member] | Prime Rate [Member]            
Debt Instrument Basis Spread Below Variable Rate     0.50%      
Debt Instrument, Interest Received on Daily Negative Balances, Basis Spread Below Variable Rate     2.00%      
Revolving Credit Facility [Member] | Secured Overnight Financing Rate (SOFR) Overnight Index Swap Rate [Member]            
Debt Instrument, Basis Spread on Variable Rate     1.60%      
Debt Instrument, Interest Rate, Effective Percentage 6.90%   6.90%      
Letter of Credit [Member]            
Line of Credit Facility, Maximum Borrowing Capacity $ 1,500,000   $ 1,500,000      
Factoring Agreements [Member]            
Long-Term Debt         $ 0  
Factoring Fees [Member]            
Selling, General and Administrative Expense $ 106,000 $ 77,000 $ 265,000 $ 224,000